| Post |
| Pre |
| LA |
|---|
| - |
| - |
| ME 1 | ME 2 | ME 3 | ME 4 | ME 5 | ME 6 | ME 7 | ME 8 | ME 9 | ME 10 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 17 | 576 | 185 | - | - | - | 778 |
| - | - | - | - | - | 1 | 5 | - | - | - | 6 |
| Post |
| Pre |
| LO 1 | LO 2 | LO 3 | LO 4 | LO 5A | LO 5B | LO 6 | Total |
|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - |
| AME |
|---|
| 334 |
| 241 |
| Post |
| Pre |
| LOP 1 | LOP 2 | LOP 3 | LOP 4 | Total |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
| central brain |
|---|
| 1,182 |
| 472 |

| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| ME(L) | 778 | 31.0% | -7.02 | 6 | 0.7% |
| PLP(R) | 334 | 13.3% | 0.33 | 420 | 52.2% |
| PLP(L) | 534 | 21.3% | -8.06 | 2 | 0.2% |
| AME(R) | 233 | 9.3% | 0.04 | 240 | 29.8% |
| CentralBrain-unspecified | 314 | 12.5% | -2.68 | 49 | 6.1% |
| Optic-unspecified(L) | 178 | 7.1% | -6.48 | 2 | 0.2% |
| AME(L) | 101 | 4.0% | -6.66 | 1 | 0.1% |
| Optic-unspecified(R) | 31 | 1.2% | 0.18 | 35 | 4.3% |
| ME(R) | 7 | 0.3% | 2.81 | 49 | 6.1% |
| IPS(R) | 0 | 0.0% | inf | 1 | 0.1% |
| upstream partner | # | NT | conns MeVPaMe2 | % In | CV |
|---|---|---|---|---|---|
| aMe5 (R) | 17 | ACh | 468 | 19.4% | 0.5 |
| aMe5 (L) | 21 | ACh | 306 | 12.7% | 0.7 |
| Mi15 (L) | 71 | ACh | 142 | 5.9% | 0.7 |
| Cm20 (L) | 12 | GABA | 115 | 4.8% | 0.6 |
| MeVC20 (L) | 2 | Glu | 103 | 4.3% | 0.2 |
| aMe30 (L) | 3 | Glu | 100 | 4.1% | 0.1 |
| MeTu3b (L) | 20 | ACh | 95 | 3.9% | 0.8 |
| aMe10 (R) | 2 | ACh | 84 | 3.5% | 0.0 |
| MeVP5 (L) | 8 | ACh | 79 | 3.3% | 0.6 |
| MeVP10 (L) | 16 | ACh | 72 | 3.0% | 0.7 |
| Mi10 (L) | 32 | ACh | 60 | 2.5% | 0.7 |
| aMe10 (L) | 1 | ACh | 55 | 2.3% | 0.0 |
| MeVP3 (L) | 17 | ACh | 55 | 2.3% | 0.8 |
| aMe24 (L) | 1 | Glu | 44 | 1.8% | 0.0 |
| Cm-DRA (L) | 4 | ACh | 38 | 1.6% | 0.4 |
| aMe_unclear (L) | 1 | Glu | 36 | 1.5% | 0.0 |
| MeTu1 (L) | 17 | ACh | 35 | 1.4% | 0.7 |
| aMe6b (L) | 1 | ACh | 34 | 1.4% | 0.0 |
| MeVP5 (R) | 8 | ACh | 34 | 1.4% | 0.5 |
| MeVP21 (L) | 3 | ACh | 33 | 1.4% | 0.4 |
| aMe12 (L) | 4 | ACh | 25 | 1.0% | 0.5 |
| MeVP31 (L) | 1 | ACh | 23 | 1.0% | 0.0 |
| aMe26 (L) | 3 | ACh | 18 | 0.7% | 0.5 |
| MeVP12 (L) | 5 | ACh | 15 | 0.6% | 0.9 |
| mALD1 (R) | 1 | GABA | 14 | 0.6% | 0.0 |
| Cm14 (L) | 7 | GABA | 14 | 0.6% | 0.7 |
| aMe30 (R) | 2 | Glu | 13 | 0.5% | 0.2 |
| Cm3 (L) | 5 | GABA | 12 | 0.5% | 1.0 |
| aMe1 (R) | 2 | GABA | 12 | 0.5% | 0.2 |
| MeVPMe11 (R) | 1 | Glu | 11 | 0.5% | 0.0 |
| MeTu3a (L) | 8 | ACh | 11 | 0.5% | 0.4 |
| aMe12 (R) | 2 | ACh | 9 | 0.4% | 0.3 |
| Cm30 (L) | 2 | GABA | 9 | 0.4% | 0.3 |
| aMe9 (L) | 2 | ACh | 9 | 0.4% | 0.1 |
| PLP129 (L) | 1 | GABA | 8 | 0.3% | 0.0 |
| OA-AL2i3 (R) | 2 | OA | 8 | 0.3% | 0.8 |
| MeTu3c (L) | 6 | ACh | 8 | 0.3% | 0.6 |
| Dm2 (L) | 7 | ACh | 8 | 0.3% | 0.3 |
| Cm11d (L) | 3 | ACh | 7 | 0.3% | 0.8 |
| MeLo1 (L) | 5 | ACh | 7 | 0.3% | 0.3 |
| aMe2 (R) | 3 | Glu | 6 | 0.2% | 0.4 |
| aMe15 (L) | 1 | ACh | 5 | 0.2% | 0.0 |
| MeVPaMe2 (R) | 1 | Glu | 5 | 0.2% | 0.0 |
| MeVPLo2 (L) | 2 | ACh | 5 | 0.2% | 0.6 |
| MeVP22 (R) | 2 | GABA | 5 | 0.2% | 0.2 |
| MeLo6 (L) | 4 | ACh | 5 | 0.2% | 0.3 |
| AOTU056 (L) | 3 | GABA | 5 | 0.2% | 0.3 |
| LoVCLo3 (R) | 1 | OA | 4 | 0.2% | 0.0 |
| Tm39 (L) | 2 | ACh | 4 | 0.2% | 0.5 |
| OCG02c (L) | 2 | ACh | 4 | 0.2% | 0.5 |
| MeVC22 (R) | 2 | Glu | 4 | 0.2% | 0.5 |
| Cm31a (L) | 2 | GABA | 4 | 0.2% | 0.5 |
| Tm5c (L) | 3 | Glu | 4 | 0.2% | 0.4 |
| Dm-DRA1 (L) | 3 | Glu | 4 | 0.2% | 0.4 |
| Cm12 (L) | 3 | GABA | 4 | 0.2% | 0.4 |
| AOTU056 (R) | 1 | GABA | 3 | 0.1% | 0.0 |
| aMe2 (L) | 1 | Glu | 3 | 0.1% | 0.0 |
| aMe3 (R) | 1 | Glu | 3 | 0.1% | 0.0 |
| Cm31b (L) | 1 | GABA | 3 | 0.1% | 0.0 |
| Cm4 (L) | 2 | Glu | 3 | 0.1% | 0.3 |
| MeVP12 (R) | 2 | ACh | 3 | 0.1% | 0.3 |
| MeVP1 (L) | 3 | ACh | 3 | 0.1% | 0.0 |
| MeTu2a (L) | 3 | ACh | 3 | 0.1% | 0.0 |
| MeVP9 (L) | 3 | ACh | 3 | 0.1% | 0.0 |
| Cm22 (L) | 1 | GABA | 2 | 0.1% | 0.0 |
| Cm9 (L) | 1 | Glu | 2 | 0.1% | 0.0 |
| SLP344 (L) | 1 | Glu | 2 | 0.1% | 0.0 |
| LHPD1b1 (L) | 1 | Glu | 2 | 0.1% | 0.0 |
| PLP142 (L) | 1 | GABA | 2 | 0.1% | 0.0 |
| MeVP42 (R) | 1 | ACh | 2 | 0.1% | 0.0 |
| LoVC23 (L) | 1 | GABA | 2 | 0.1% | 0.0 |
| aMe6a (R) | 1 | ACh | 2 | 0.1% | 0.0 |
| 5thsLNv_LNd6 (L) | 1 | ACh | 2 | 0.1% | 0.0 |
| MeVP25 (L) | 1 | ACh | 2 | 0.1% | 0.0 |
| MeVPMe3 (R) | 1 | Glu | 2 | 0.1% | 0.0 |
| aMe17a (L) | 1 | unc | 2 | 0.1% | 0.0 |
| MeLo3b (L) | 2 | ACh | 2 | 0.1% | 0.0 |
| MeTu3c (R) | 2 | ACh | 2 | 0.1% | 0.0 |
| MeVP7 (R) | 2 | ACh | 2 | 0.1% | 0.0 |
| MeVP14 (R) | 2 | ACh | 2 | 0.1% | 0.0 |
| Cm25 (L) | 2 | Glu | 2 | 0.1% | 0.0 |
| aMe4 (L) | 2 | ACh | 2 | 0.1% | 0.0 |
| aMe23 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| MeVP35 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| Tm38 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| PLP131 (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| MeTu2b (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeVP14 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| Dm9 (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| Cm18 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| SLP412_b (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| MeLo5 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| SMP228 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| AOTU055 (R) | 1 | GABA | 1 | 0.0% | 0.0 |
| MeTu3b (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| Cm11a (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| Cm7 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| CB1467 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| OCG02c (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| SMP217 (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| Lat3 (R) | 1 | unc | 1 | 0.0% | 0.0 |
| MeLo6 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeVP20 (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| MeLo1 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| HBeyelet (R) | 1 | HA | 1 | 0.0% | 0.0 |
| Li20 (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| CL086_c (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeVPLo2 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| aMe6b (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeVPMe10 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| MeVP63 (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| PS272 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| aMe8 (R) | 1 | unc | 1 | 0.0% | 0.0 |
| MeVP40 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| aMe9 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeVP32 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| LoVP42 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeVC20 (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| aMe4 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeVC21 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| MeVC8 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| LoVP96 (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| LoVP96 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| MeVPaMe1 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeVP41 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| aMe17b (R) | 1 | GABA | 1 | 0.0% | 0.0 |
| MeVC21 (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| MeVP29 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| LHPD5a1 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| MeVPMe6 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| Pm13 (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| Cm35 (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| CL357 (R) | 1 | unc | 1 | 0.0% | 0.0 |
| OA-VUMa3 (M) | 1 | OA | 1 | 0.0% | 0.0 |
| MeVPMe1 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| OA-VUMa6 (M) | 1 | OA | 1 | 0.0% | 0.0 |
| downstream partner | # | NT | conns MeVPaMe2 | % Out | CV |
|---|---|---|---|---|---|
| aMe30 (R) | 2 | Glu | 165 | 8.8% | 0.1 |
| aMe17e (R) | 1 | Glu | 163 | 8.7% | 0.0 |
| MeVC22 (R) | 2 | Glu | 127 | 6.8% | 0.0 |
| Lat1 (R) | 4 | unc | 82 | 4.4% | 0.6 |
| CL125 (R) | 2 | Glu | 75 | 4.0% | 0.1 |
| LoVP53 (R) | 1 | ACh | 70 | 3.7% | 0.0 |
| aMe8 (R) | 2 | unc | 70 | 3.7% | 0.3 |
| DNpe021 (R) | 1 | ACh | 61 | 3.3% | 0.0 |
| aMe6a (R) | 1 | ACh | 61 | 3.3% | 0.0 |
| aMe3 (R) | 1 | Glu | 59 | 3.2% | 0.0 |
| MeTu3b (R) | 4 | ACh | 59 | 3.2% | 0.3 |
| CL063 (R) | 1 | GABA | 47 | 2.5% | 0.0 |
| LoVP96 (R) | 1 | Glu | 38 | 2.0% | 0.0 |
| MeTu3c (R) | 7 | ACh | 38 | 2.0% | 0.6 |
| aMe15 (R) | 1 | ACh | 32 | 1.7% | 0.0 |
| SLP250 (R) | 1 | Glu | 31 | 1.7% | 0.0 |
| aMe_TBD1 (R) | 1 | GABA | 30 | 1.6% | 0.0 |
| PLP174 (R) | 2 | ACh | 30 | 1.6% | 0.3 |
| Cm8 (R) | 9 | GABA | 27 | 1.4% | 0.9 |
| MeVP39 (R) | 1 | GABA | 26 | 1.4% | 0.0 |
| MeVP63 (R) | 1 | GABA | 26 | 1.4% | 0.0 |
| AOTU058 (R) | 4 | GABA | 24 | 1.3% | 0.7 |
| LPLC2 (R) | 8 | ACh | 24 | 1.3% | 0.6 |
| MeVP29 (R) | 1 | ACh | 23 | 1.2% | 0.0 |
| AOTU056 (R) | 4 | GABA | 23 | 1.2% | 0.8 |
| SMP200 (R) | 1 | Glu | 22 | 1.2% | 0.0 |
| Lawf1 (R) | 3 | ACh | 22 | 1.2% | 1.0 |
| MeVC21 (R) | 2 | Glu | 21 | 1.1% | 0.0 |
| aMe5 (R) | 9 | ACh | 19 | 1.0% | 0.4 |
| MeVPaMe1 (R) | 1 | ACh | 18 | 1.0% | 0.0 |
| Pm13 (R) | 1 | Glu | 16 | 0.9% | 0.0 |
| Tm5c (R) | 8 | Glu | 16 | 0.9% | 0.5 |
| LoVCLo3 (L) | 1 | OA | 13 | 0.7% | 0.0 |
| aMe6c (R) | 1 | Glu | 12 | 0.6% | 0.0 |
| aMe1 (R) | 1 | GABA | 11 | 0.6% | 0.0 |
| MeVP40 (R) | 1 | ACh | 11 | 0.6% | 0.0 |
| LoVP54 (R) | 1 | ACh | 11 | 0.6% | 0.0 |
| LoVCLo3 (R) | 1 | OA | 11 | 0.6% | 0.0 |
| OA-AL2i3 (R) | 2 | OA | 10 | 0.5% | 0.4 |
| MeTu1 (R) | 6 | ACh | 10 | 0.5% | 0.4 |
| aMe13 (R) | 1 | ACh | 9 | 0.5% | 0.0 |
| SMP530_a (R) | 1 | Glu | 8 | 0.4% | 0.0 |
| MeVP14 (R) | 4 | ACh | 8 | 0.4% | 0.4 |
| MeVP21 (R) | 2 | ACh | 7 | 0.4% | 0.7 |
| MeVP7 (R) | 3 | ACh | 7 | 0.4% | 0.5 |
| aMe10 (R) | 2 | ACh | 7 | 0.4% | 0.1 |
| SMP331 (R) | 1 | ACh | 6 | 0.3% | 0.0 |
| aMe17c (R) | 1 | Glu | 6 | 0.3% | 0.0 |
| MeTu3b (L) | 3 | ACh | 6 | 0.3% | 0.4 |
| LC36 (R) | 1 | ACh | 5 | 0.3% | 0.0 |
| Cm31b (R) | 1 | GABA | 5 | 0.3% | 0.0 |
| Tm5Y (R) | 2 | ACh | 5 | 0.3% | 0.6 |
| SLP322 (R) | 2 | ACh | 5 | 0.3% | 0.2 |
| SLP295 (R) | 1 | Glu | 4 | 0.2% | 0.0 |
| Cm12 (R) | 1 | GABA | 4 | 0.2% | 0.0 |
| aMe23 (R) | 1 | Glu | 4 | 0.2% | 0.0 |
| PLP094 (R) | 1 | ACh | 4 | 0.2% | 0.0 |
| MeVP33 (R) | 1 | ACh | 4 | 0.2% | 0.0 |
| aMe12 (R) | 1 | ACh | 4 | 0.2% | 0.0 |
| AOTU055 (R) | 2 | GABA | 4 | 0.2% | 0.5 |
| aMe2 (R) | 2 | Glu | 4 | 0.2% | 0.0 |
| MeTu3a (L) | 3 | ACh | 4 | 0.2% | 0.4 |
| Cm5 (R) | 1 | GABA | 3 | 0.2% | 0.0 |
| SMP217 (R) | 1 | Glu | 3 | 0.2% | 0.0 |
| CL073 (R) | 1 | ACh | 3 | 0.2% | 0.0 |
| LoVP60 (R) | 1 | ACh | 3 | 0.2% | 0.0 |
| SLP249 (R) | 1 | Glu | 3 | 0.2% | 0.0 |
| aMe25 (R) | 1 | Glu | 3 | 0.2% | 0.0 |
| MeVP25 (R) | 1 | ACh | 3 | 0.2% | 0.0 |
| aMe17b (R) | 1 | GABA | 3 | 0.2% | 0.0 |
| MeVPMe6 (L) | 1 | Glu | 3 | 0.2% | 0.0 |
| MeVC23 (R) | 1 | Glu | 3 | 0.2% | 0.0 |
| DNp27 (R) | 1 | ACh | 3 | 0.2% | 0.0 |
| Cm11d (R) | 2 | ACh | 3 | 0.2% | 0.3 |
| LoVP38 (R) | 2 | Glu | 3 | 0.2% | 0.3 |
| aMe4 (R) | 2 | ACh | 3 | 0.2% | 0.3 |
| l-LNv (R) | 2 | unc | 3 | 0.2% | 0.3 |
| aMe4 (L) | 3 | ACh | 3 | 0.2% | 0.0 |
| Cm20 (R) | 1 | GABA | 2 | 0.1% | 0.0 |
| Cm22 (R) | 1 | GABA | 2 | 0.1% | 0.0 |
| aMe10 (L) | 1 | ACh | 2 | 0.1% | 0.0 |
| MeVP18 (R) | 1 | Glu | 2 | 0.1% | 0.0 |
| LT43 (R) | 1 | GABA | 2 | 0.1% | 0.0 |
| PLP069 (L) | 1 | Glu | 2 | 0.1% | 0.0 |
| AVLP571 (R) | 1 | ACh | 2 | 0.1% | 0.0 |
| 5thsLNv_LNd6 (R) | 1 | ACh | 2 | 0.1% | 0.0 |
| MeVP29 (L) | 1 | ACh | 2 | 0.1% | 0.0 |
| Cm21 (R) | 2 | GABA | 2 | 0.1% | 0.0 |
| Cm30 (L) | 2 | GABA | 2 | 0.1% | 0.0 |
| CB0670 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVPMe10 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| SMP527 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| aMe22 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| CL357 (L) | 1 | unc | 1 | 0.1% | 0.0 |
| Cm14 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| SMP528 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| Dm2 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| LoVP9 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| CB2671 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| Tm39 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| Cm6 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| Cm3 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| Dm-DRA1 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| Cm9 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| Cm22 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| Cm11a (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| FB8B (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeLo6 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVP1 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| CB0937 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| Cm10 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| MeVP12 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| aMe5 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeLo1 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| CL086_a (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| CB3676 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| LoVP41 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| aMe6b (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| CB0029 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| PS272 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVP59 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| aMe22 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVP32 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVC20 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVP30 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVPMe4 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVP43 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVPLp2 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVC20 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVPaMe1 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| Pm12 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| DNc02 (R) | 1 | unc | 1 | 0.1% | 0.0 |
| DNpe053 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVPMe13 (R) | 1 | ACh | 1 | 0.1% | 0.0 |